Similar cardioprotective effects were obtained with a p38α-selective inhibitor in an isoproterenol (ISO)-induced model of cardiac hypertrophy and dysfunction in rats (11), which suggested it was p38α, rather than p38β, which is important in mediating cardiac hypertrophy in vivo. This evidence concerns the gene MAPK11 and cardiac hypertrophy.